Request Deal Involvement

Cambrex Corporation has reached agreement to acquire Avista Pharma for $252m in cash from Ampersand Capital Partners

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Bourne Partners

financial advisors

Bourne Partners

Goodwin Procter

legal advisors

Goodwin Procter

Wells Fargo Securities

financial advisors

Wells Fargo Securities

Ropes & Gray

legal advisors

Ropes & Gray

Hogan Lovells

legal advisors

Hogan Lovells

or

Principals

AVISTA PHARMA SOLUTIONS INC.

target

AVISTA PHARMA SOLUTIONS INC.

AMPERSAND CAPITAL PARTNERS

vendor

AMPERSAND CAPITAL PARTNERS

CAMBREX CORPORATION

bidder

CAMBREX CORPORATION

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite